Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 898 of 1,261
  1. US 8314239

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Nov 20, 2012 · Expires Nov 15, 2032

    granted
  2. US 8314125

    Bicyclic derivatives as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Nov 20, 2012 · Expires Nov 15, 2032

    granted
  3. US 8314093

    2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases

    Rigel Pharmaceuticals, Inc. · Granted Nov 20, 2012 · Expires Nov 15, 2032

    granted
  4. US 8313925

    Zinc finger proteins and method for inactivating a dhfr gene in a chinese hamster ovary cell

    Sangamo Biosciences, Inc. · Granted Nov 20, 2012 · Expires Nov 15, 2032

    granted
  5. US 8313772

    Compositions for targeted delivery of siRNA

    Arrowhead Madison, Inc. · Granted Nov 20, 2012 · Expires Nov 15, 2032

    granted
  6. US 8313746

    Human monoclonal antibodies against hendra and nipah viruses

    The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Nov 20, 2012 · Expires Nov 15, 2032

    granted
  7. US 8313789

    Methods of promoting the growth of beneficial bacteria in the gut

    The United States of America, as represented by the Secretary of Agriculture · Granted Nov 20, 2012 · Expires Nov 15, 2032

    granted
  8. US 8314135

    Linked dibenzimidazole antivirals

    Enanta Pharmaceuticals, Inc. · Granted Nov 20, 2012 · Expires Nov 15, 2032

    granted
  9. US 8314122

    Using of organic solvents in wet granulation of moxifloxacin

    Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi · Granted Nov 20, 2012 · Expires Nov 15, 2032

    granted
  10. US 8314088

    Pyrazinooxazepine derivatives

    Takeda Pharmaceutical Company Limited · Granted Nov 20, 2012 · Expires Nov 15, 2032

    granted
  11. US 8314107

    Carboxamide compounds and methods for using the same

    Rigel Pharmaceuticals, Inc. · Granted Nov 20, 2012 · Expires Nov 15, 2032

    granted
  12. US 8314217

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Nov 20, 2012 · Expires Nov 15, 2032

    granted
  13. WO 2012152918

    SÉMULOPARINE POUR LA PRÉVENTION DE THROMBOEMBOLISME VEINEUX CHEZ DES PATIENTS CANCÉREUX RECEVANT UNE CHIMIOTHÉRAPIE

    AVENTIS PHARMA SA [FR] · Granted Nov 15, 2012 · Expires Nov 10, 2032

    granted
  14. US 8309566

    Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases

    Rigel Pharmaceuticals, Inc. · Granted Nov 13, 2012 · Expires Nov 8, 2032

    granted
  15. US 8309355

    Methods of treating Parkinson's disease using viral vectors

    The Regents of the University of California · Granted Nov 13, 2012 · Expires Nov 8, 2032

    granted
  16. US 8309543

    Compositions useful as inhibitors of voltage-gated sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Nov 13, 2012 · Expires Nov 8, 2032

    granted
  17. US 8309565

    Phosphonate compounds

    The Regents of the University of California · Granted Nov 13, 2012 · Expires Nov 8, 2032

    granted
  18. US 8309527

    Immunomodulatory oligonucleotides

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 13, 2012 · Expires Nov 8, 2032

    granted
  19. US 8309595

    Hydrazone modulators of cannabinoid receptors

    The Board of Regents of the University of Texas System · Granted Nov 13, 2012 · Expires Nov 8, 2032

    granted
  20. US 8309680

    Segmented degradable polymers and conjugates made therefrom

    Nektar Therapeutics · Granted Nov 13, 2012 · Expires Nov 8, 2032

    granted
  21. US 8309526

    Nitrated lipids and methods of making and using thereof

    University College Cardiff Consultants Limited · Granted Nov 13, 2012 · Expires Nov 8, 2032

    granted
  22. US 8309525

    Treatment of type 2 diabetes, metabolic syndrome, myocardial injury and neurodegeneration with humanin and analogs thereof

    The Regents of the University of California · Granted Nov 13, 2012 · Expires Nov 8, 2032

    granted
  23. US 8309350

    Photoreactive regulator of protein function and methods of use thereof

    The Regents of the University of California · Granted Nov 13, 2012 · Expires Nov 8, 2032

    granted
  24. US 8309088

    Method of treating osteoarthritis with an antibody to NGF

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 13, 2012 · Expires Nov 8, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.